PharmaNordic ApS: Financial statements 2018
CVR: 36408464
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 476,274 and a net result of DKK 109,472 compared with DKK -51,053 the year before. That is an increase of 96.7% compared with the year before. Equity in the 2018 report amounted to DKK -141,077.
- Gross Profit
- DKK 476,274
- Profit/Loss
- DKK 109,472
- Equity
- DKK -141,077
- Total Assets
- DKK 282,347
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 476 t. | 109 t. | -141 t. | - |
| 2017 | - | 242 t. | -51 t. | -251 t. | - |
| 2016 | - | 190 t. | -65 t. | -199 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PharmaNordic ApS has published its annual report for 2017. Gross profit came to DKK 242,124, and the net result was DKK -51,053.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.